Medicare Enrolled
Dr. Tony Das, MD
Cardiovascular Disease · Dallas, TX
Practice pattern: Cardiac Imaging— Practice with significant diagnostic imaging and stress testing
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Das from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Das? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Das
Dr. Tony Das is a cardiovascular disease in Dallas, TX, with 20 years in practice. Based on federal Medicare data, Dr. Das performed 8,141 Medicare services across 5,413 unique beneficiaries.
Between the years covered by Open Payments, Dr. Das received a total of $72,133 from 72 pharmaceutical and/or device companies across 368 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Das is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 6% volume in TX$ $72,133 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,141
Medicare services
Top 6% in TX for cardiovascular disease
5,413
Unique beneficiaries
$104
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~407 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Regadenoson injection (Lexiscan) for heart stress test | 1,668 | $42 | $500 |
| Office visit, established patient (30-39 min) | 1,525 | $90 | $278 |
| Echocardiogram, transthoracic | 685 | $142 | $532 |
| Electrocardiogram (EKG), 12-lead | 644 | $11 | $44 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 534 | $48 | $183 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 528 | $341 | $1,240 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 396 | $194 | $992 |
| Office visit, established patient, complex (40-54 min) | 292 | $124 | $371 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 247 | $105 | $247 |
| Ultrasound of both sides of head and neck blood flow | 199 | $136 | $519 |
| Office visit, established patient (20-29 min) | 168 | $64 | $190 |
| New patient office visit, complex (60-74 min) | 157 | $153 | $526 |
| Ultrasound of leg arteries or artery grafts | 144 | $179 | $660 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 140 | $195 | $993 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 130 | $134 | $503 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 85 | $27 | $94 |
| Injection, aminophyllin, up to 250 mg | 78 | $6 | $20 |
| Cardiac catheterization | 66 | $157 | $2,669 |
| Programming of dual lead pacemaker system | 62 | $53 | $167 |
| Insertion of tube into aorta | 53 | $51 | $1,086 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial second order branch | 45 | $93 | $1,465 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 42 | $114 | $3,028 |
| Coronary stent placement | 40 | $415 | $1,518 |
| Remote patient monitoring device, 30 days | 31 | $40 | $161 |
| Remote patient monitoring management, 20 min/month | 31 | $39 | $128 |
| Ultrasound scan of abdominal aorta | 25 | $104 | $292 |
| New patient office visit (45-59 min) | 24 | $105 | $418 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 16 | $54 | $600 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 16 | $11 | $132 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 15 | $93 | $312 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 15 | $15 | $50 |
| Review by radiologist of both arms or legs arteries image | 14 | $70 | $298 |
| Review by radiologist of additional artery image | 14 | $34 | $167 |
| Review by radiologist of arm or leg artery image | 12 | $63 | $298 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.5% high complexity
41.0% medium
48.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$72,133
Total received (2018-2024)
Avg $10,305/year across 7 years
Top 8% in TX for cardiovascular disease
72
Companies
368
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$51,973 (72.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,959 (22.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,201 (5.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$27,962
2023$4,333
2022$4,114
2021$21,510
2020$4,275
2019$6,036
2018$3,903
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Acarix USA Inc.
$19,961
Elucid
$16,000
Boston Scientific Corporation
$5,582
Medtronic, Inc.
$5,169
BIOTRONIK INC.
$4,240
CORDIS US CORP.
$3,830
Cardinal Health 200 LLC
$2,500
AngioDynamics, Inc.
$1,565
Cardiovascular Systems Inc.
$1,125
Silk Road Medical, Inc.
$1,085
Abbott Laboratories
$716
Endologix, Inc.
$679
Novartis Pharmaceuticals Corporation
$666
BOSTON SCIENTIFIC CORPORATION
$638
Endologix LLC
$617
HeartFlow, Inc.
$564
W. L. Gore & Associates, Inc.
$528
Edwards Lifesciences Corporation
$484
Endologix, LLC
$478
InspireMD Ltd
$425
BARD PERIPHERAL VASCULAR, INC.
$381
Inari Medical, Inc.
$369
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$328
HEARTFLOW, INC.
$316
Amplitude Vascular Systems, Inc.
$278
Janssen Pharmaceuticals, Inc
$274
Amgen Inc.
$242
ShockWave Medical, Inc
$230
Surmodics, Inc.
$229
E.R. Squibb & Sons, L.L.C.
$211
PFIZER INC.
$206
Amarin Pharma Inc.
$199
EKOS Corporation
$180
ABIOMED
$157
Shockwave Medical, Inc
$134
Galderma Laboratories, L.P.
$117
Veryan Medical Incorporated
$115
Boehringer Ingelheim Pharmaceuticals, Inc.
$104
Merck Sharp & Dohme LLC
$95
SANOFI-AVENTIS U.S. LLC
$94
Philips Electronics North America Corporation
$88
Tactile Systems Technology Inc
$85
Esperion Therapeutics, Inc.
$84
Cleerly, Inc.
$61
Astellas Pharma US Inc
$61
Impulse Dynamics (USA) Inc.
$50
Biosense Webster, Inc.
$45
Bolton Medical Inc
$43
Cardinal Health 200, LLC
$43
Philips North America LLC
$41
Merck Sharp & Dohme Corporation
$41
Getinge USA Sales, LLC
$27
Contego Medical, Inc
$25
Medtronic Vascular, Inc.
$25
Arineta, Inc
$23
Lexicon Pharmaceuticals, Inc.
$21
Coala Life Inc
$21
Siemens Medical Solutions USA, Inc.
$20
Osprey Medical Inc
$19
Vital Connect, Inc
$19
Avinger Inc.
$18
SCPHARMACEUTICALS INC.
$18
iRhythm Technologies, Inc.
$17
Novo Nordisk Inc
$16
Intact Vascular, Inc.
$16
AstraZeneca Pharmaceuticals LP
$16
Terumo Medical Corporation
$16
CHIESI USA, INC.
$14
Kowa Pharmaceuticals America, Inc.
$13
Regeneron Healthcare Solutions, Inc.
$12
ARALEZ PHARMACEUTICALS US INC.
$12
Chiesi USA, Inc.
$11
Top 3 companies account for 57.6% of total payments
Associated products mentioned in payments ›
(1262) Large scale upgrades · (CK4) MCOT · ACCOLADE · ALPHAVAC · ANGIOGUARD · AURYON LASER SYSTEM 100-120 VAC · AZURE XT DR MRI SURESCAN · Acticor · Acticor 7 VR-T DX · Alto Abdominal Stent Graft System · Artis Q · Auryon Laser System 100-120 Vac · BIOMONITOR · BRILINTA · BioMimics · C3 Delivery System · CADScor System · CAMZYOS · CARTO 3 · CGuard · CONFIRM RX · COREVALVE EVOLUT R · CardioGraphe · Cleerly Ischemia · ClosureFast · Coala Heart Monitor · Corlanor · Diamondback Peripheral · DyeVert · EKOSONIC · ELIQUIS · ENDOCROSS Device · ENROUTE Transcarotid Neuroprotection System · ENROUTE Transcarotid Stent · ENTRESTO · ESPRIT · ESSENTIO SR · EXCLUDER Conformable AAA Endoprosthesis with Active Control · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · ElucidVivo · Endo · FFRct · FLEXITOUCH · FLIXENE · FLOWTRIEVER CATHETER · FUROSCIX · Flexitouch Plus · FlowTriever · GENERAL THERAPIES · GENERAL VASCULAR INTERVENTION · GENERAL - VASCULAR INTERVENTION · GENERAL METALLIC STENTS · GENERAL NONVASCULAR INTERVENTION · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · GORE TAG Thoracic Endoprosthesis · Glidesheath · Grafts · HawkOne · IN.PACT ADMIRAL · INGEVITY · Image Guided Therapy Devices _ Therapy · Impella · Inpefa · JARDIANCE · JOT DX · KENGREAL · KENGREAL 50MG/10ML L · LEQVIO · LEXISCAN · LUX DX · LUX-DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MICRA · MULTAQ · Mitra Clip system · MynxGrip Vascular Closure Device · NEXLETOL · ONYX FRONTIER · OPTIS · Optimizer · Ovation · Ozempic · PANTHERIS · PK Papyrus · PRALUENT ALIROCUMAB INJECTION · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · Proclaim Family of SCS IPGs · RADIAL 360 · RESONATE · Repatha · S · SAPIEN 3 Ultra RESILIA · SELUTION SLRPTA · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SYMPLICITY G3 · Sublime 014 Rx PTA Balloon Dilatation Catheter · TREO ABDOMINAL STENT-GRAFT SYSTEM · Tack Endovascular System · VALITUDE · VENASEAL · VERQUVO · VIABAHN Endoprosthesis with Heparin Bioactive Surface · VIGILANT · VISTA BRITE · VYNDAQEL · Vascepa · Vascular Lithotripsy · VenaSeal · WATCHMAN · WATCHMAN Access System · WaveWriter Alpha Prime 16 · XARELTO · XIENCE V · ZIO XT Patch · ZONTIVITY · cguard
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (72%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 8% for cardiovascular disease in TX.
Equivalent to $886 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
312
Per 100K population
12.0
County median income
$74,149
Nearest hospital
MEDICAL CITY DALLAS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Das is a cardiac imaging specialist, with above-average Medicare volume (top 6% in TX), and high industry engagement (consulting-driven, top 8%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Das experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Das performed 1,668 regadenoson injection (lexiscan) for heart stress test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Das receive payments from pharmaceutical companies?
Yes. Dr. Das received a total of $72,133 from 72 companies across 368 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Das's costs compare to other cardiovascular diseases in Dallas?
Dr. Das's average Medicare payment per service is $104. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Das) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Dallas
Browse cardiovascular diseases in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Acarix USA Inc. Payments to Doctors
See all physicians who received payments from Acarix USA Inc..
By company
Elucid Payments to Doctors
See all physicians who received payments from Elucid.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology